The procedure involves targeted ovarian injection of regenerative cells, performed either through a transvaginal ultrasound-guided approach or a laparoscopic approach, depending on the patient’s ovarian anatomy. The therapy stimulates tissue repair and microvascular growth within the ovarian cortex, gradually restoring hormone production and follicular activity over the following weeks.
Clinical follow-up typically shows a measurable improvement in AMH levels, decreased FSH, and enhanced ovarian response during subsequent IVF cycles. This approach offers new hope to women who previously faced limited fertility options, combining science, precision, and compassionate care under one program.
All ovarian procedures at WIH are conducted in a hospital-grade sterile operating theater under the supervision of gynecologists, anesthesiologists, and regenerative medicine experts to ensure optimal results and patient safety